The company helped spur a public health crisis through its deceptive marketing and aggressive sales of prescription opioids.
Rigor académico, oficio periodístico
Artículos sobre Opioid settlements
Mostrando todos artículos
A group of academics look at the global evidence to examine the potential impact of supervised injection sites in Philadelphia and the US.
Making them pay is important but it’s not going to stop drugmakers from endangering public health.
After battling drug manufacturers and distributors in court for years, local and state governments are about to receive a windfall that could expand access to treatments that can save lives.
The multibillion-dollar settlement will trigger the release of troves of documents that may shine new light on what caused the opioid crisis.
Principales colaboradores
-
Associate Professor of History, University at Buffalo
-
Researcher Fellow at the Centre for Sustainable Healthcare Education, University of Oslo
-
Associate Professor of Sociology, Saint Louis University
-
Professor of Law, Temple University
-
Visiting Fellow at the Center for Public Policy, Drexel University
-
Postdoctoral Fellow in Sociology, University of Oslo
-
Assistant Professor of History, University of California, Riverside
-
Associate Professor of Criminology and Justice Studies, Drexel University
